In a recent statement, a US deputy health secretary emphasized that federal vaccine guidelines are not final and remain subject to updates based on emerging scientific data. The official noted that agencies like the CDC and NIH are continuously reviewing new research, particularly concerning vaccine efficacy and longevity. This adaptive approach is part of a broader strategy by ARPA-H and other health bodies to ensure public health recommendations reflect the most current evidence. The evolving nature of the guidance underscores the government’s commitment to a responsive and science-driven pandemic response framework. Read the full article at: https://www.technologyreview.com/2026/02/13/1132889/us-deputy-health-secretary-vaccine-guidelines-longevity-arpa-h-cdc-nih/